Skip to Content

Quazepam Pregnancy and Breastfeeding Warnings

Quazepam is also known as: Doral

Quazepam Pregnancy Warnings

Animal models have failed to reveal evidence of morphological development. However, data for other benzodiazepines have indicated possible adverse developmental effects (long-term effects on neurobehavioral and immunological function) in animals. There are no controlled data in human pregnancy US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. US FDA pregnancy category: C Comments: -A syndrome of hypothermia, hypotonia, respiratory depression and difficulty feeding may occur in in infants of mothers administered benzodiazepines immediately prior to or during childbirth. -Withdrawal symptoms may occur in neonates whose mothers were taking benzodiazepines late in pregnancy.

See references

Quazepam Breastfeeding Warnings

Use with caution. Excreted into human milk: Yes Comments: -The American Academy of Pediatrics considers this agent a drug for which the effect on nursing infants is unknown but may be of concern, especially when used for long periods. -This drug and its metabolites are excreted into human milk and both the drug and its metabolites may accumulate in the breastfed infant. Some experts recommend that an alternative drug should be considered, especially for newborn or preterm infants (e.g., zaleplon, zolpidem).

Based on a study in 4 women receiving a single dose of 15 mg, estimated human milk concentrations of 2.3% maternal weight-adjusted dose are achieved. Due to the expected accumulation with repeat dosing, an exclusively breastfed infant may receive 0.19% of the mother's absolute dose or 4% of the maternal weight-adjusted dose.

See references

References for pregnancy information

  1. "Product Information. Doral (quazepam)." Wallace Laboratories, Cranbury, NJ.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. Doral (quazepam)." Wallace Laboratories, Cranbury, NJ.
  3. Briggs GG, Freeman RK. "Drugs in Pregnancy and Lactation. 10th ed." Philadelphia, PA: Wolters Kluwer Health (2015):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.